Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

被引:784
|
作者
Minegishi, Yoshiyuki [1 ]
Saito, Masako
Tsuchiya, Shigeru
Tsuge, Ikuya
Takada, Hidetoshi
Hara, Toshiro
Kawamura, Nobuaki
Ariga, Tadashi
Pasic, Srdjan
Stojkovic, Oliver
Metin, Ayse
Karasuyama, Hajime
机构
[1] Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138519, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 9808575, Japan
[3] Fujita Hlth Univ, Dept Pediat, Aichi 4701192, Japan
[4] Kyushu Univ, Dept Pediat, Fukuoka 8128582, Japan
[5] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan
[6] Mother & Child Hlth Inst Serbia, Belgrade 11070, Serbia
[7] Univ Belgrade, Inst Forens Med, Lab Forens Genet, Belgrade 11070, Serbia
[8] SB Ankara Diskapi Childrens Hosp, Dept Pediat Immunol, TR-06110 Ankara, Turkey
关键词
D O I
10.1038/nature06096
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hyper-immunoglobulin E syndrome (HIES) is a compound primary immunodeficiency characterized by a highly elevated serum IgE, recurrent staphylococcal skin abscesses and cyst-forming pneumonia, with disproportionately milder inflammatory responses, referred to as cold abscesses, and skeletal abnormalities(1). Although some cases of familial HIES with autosomal dominant or recessive inheritance have been reported, most cases of HIES are sporadic, and their pathogenesis has remained mysterious for a long time. Here we show that dominant-negative mutations in the human signal transducer and activator of transcription 3 (STAT3) gene result in the classical multisystem HIES. We found that eight out of fifteen unrelated non-familial HIES patients had heterozygous STAT3 mutations, but their parents and siblings did not have the mutant STAT3 alleles, suggesting that these were de novo mutations. Five different mutations were found, all of which were located in the STAT3 DNA-binding domain. The patients' peripheral blood cells showed defective responses to cytokines, including interleukin (IL)-6 and IL-10, and the DNA-binding ability of STAT3 in these cells was greatly diminished. All five mutants were non-functional by themselves and showed dominant-negative effects when co-expressed with wild-type STAT3. These results highlight the multiple roles played by STAT3 in humans, and underline the critical involvement of multiple cytokine pathways in the pathogenesis of HIES.
引用
收藏
页码:1058 / U10
页数:6
相关论文
共 50 条
  • [1] Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
    Yoshiyuki Minegishi
    Masako Saito
    Shigeru Tsuchiya
    Ikuya Tsuge
    Hidetoshi Takada
    Toshiro Hara
    Nobuaki Kawamura
    Tadashi Ariga
    Srdjan Pasic
    Oliver Stojkovic
    Ayse Metin
    Hajime Karasuyama
    Nature, 2007, 448 : 1058 - 1062
  • [2] Dominant negative STAT-3 mutations in hyper-IgE syndrome
    Dereure, O.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (05): : 432 - 432
  • [3] STAT3 mutations in the hyper-IgE syndrome
    Holland, Steven M.
    Deleo, Frank R.
    Elloumi, Houda Z.
    Hsu, Amy P.
    Uzel, Gulbu
    Brodsky, Nina
    Freeman, Alexandra F.
    Demidowich, Andrew
    Davis, Joie
    Turner, Maria L.
    Anderson, Victoria L.
    Darnell, Dirk N.
    Welch, Pamela A.
    Kuhns, Douglas B.
    Frucht, David M.
    Malech, Harry L.
    Gallin, John I.
    Kobayashi, Scott D.
    Whitney, Adeline R.
    Voyich, Jovanka M.
    Musser, James M.
    Woellner, Cristina
    Schaeffer, Alejandro A.
    Puck, Jennifer M.
    Grimbacher, Bodo
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1608 - 1619
  • [4] ALLOGENEIC HSCT IMPROVES QUALITY OF LIFE IN PATIENTS WITH STAT3 DOMINANT-NEGATIVE HYPER-IGE SYNDROME
    Tsilifis, Christo
    Ciznar, Peter
    Slatter, Mary
    Worth, Austen
    Freeman, Alexandra
    Gennery, Andrew
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 395 - 395
  • [5] HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR STAT3 DOMINANT-NEGATIVE HYPER-IGE SYNDROME: INTERNATIONAL STUDY
    Tsilifis, Christo
    Oikonomopoulou, Christina
    Uppuluri, Ramya
    Yanagimachi, Masakatsu
    Haraldsson, Asgeir
    Wong, Melanie
    Keogh, Steven J.
    Gray, Paul
    Mitchell, Richard
    Raum, Michael
    Ciznar, Peter
    Gonzalez, Corina
    Dimitrova, Dimana
    Kanakry, Jennifer
    Bigley, Venetia
    Slatter, Mary A.
    Patel, Niraj
    Buddingh, Emilie P.
    Medinger, Michael
    Renke, Joanna
    Hauck, Fabian
    Albert, Michael H.
    Worth, Austen
    Freeman, Alexandra F.
    Gennery, Andrew R.
    BONE MARROW TRANSPLANTATION, 2024, 59 : 90 - 91
  • [6] Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophils
    Rubey, Kathryn M.
    Freeman, Alexandra
    Mukhitov, Alexander R.
    Paris, Andrew J.
    Lin, Susan M.
    Rue, Ryan
    Fazelinia, Hossein
    Spruce, Lynn A.
    Roof, Jennifer
    Brenner, Jacob S.
    Heimall, Jennifer
    Krymskaya, Vera P.
    LIFE SCIENCE ALLIANCE, 2024, 7 (11)
  • [7] Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
    Woellner, Cristina
    Gertz, E. Michael
    Schaeffer, Alejandro A.
    Lagos, Macarena
    Perro, Mario
    Glocker, Erik-Oliver
    Pietrogrande, Maria C.
    Cossu, Fausto
    Franco, Josee L.
    Matamoros, Nuria
    Pietrucha, Barbara
    Heropolitanska-Pliszka, Edyta
    Yeganeh, Mehdi
    Moin, Mostafa
    Espanol, Teresa
    Ehl, Stephan
    Gennery, Andrew R.
    Abinun, Mario
    Breborowicz, Anna
    Niehues, Tim
    Kilic, Sara Sebnem
    Junker, Anne
    Turvey, Stuart E.
    Plebani, Alessandro
    Sanchez, Berta
    Garty, Ben-Zion
    Pignata, Claudio
    Cancrini, Caterina
    Litzman, Jiri
    Sanal, Oezden
    Baumann, Ulrich
    Bacchetta, Rosa
    Hsu, Amy P.
    Davis, Joie N.
    Hammarstroem, Lennart
    Davies, E. Graham
    Eren, Efrem
    Arkwright, Peter D.
    Moilanen, Jukka S.
    Viemann, Dorothee
    Khan, Sujoy
    Laszlo Marodi
    Cant, Andrew J.
    Freeman, Alexandra F.
    Puck, Jennifer M.
    Holland, Steven M.
    Grimbacher, Bodo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : 424 - 432
  • [8] Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance
    Asano, Takaki
    Khourieh, Joelle
    Zhang, Peng
    Rapaport, Franck
    Spaan, Andras N.
    Li, Juan
    Lei, Wei-Te
    Pelham, Simon J.
    Hum, David
    Chrabieh, Maya
    Han, Ji Eun
    Guerin, Antoine
    Mackie, Joseph
    Gupta, Sudhir
    Saikia, Biman
    Baghdadi, Jamila E., I
    Fadil, Ilham
    Bousfiha, Aziz
    Habib, Tanwir
    Marr, Nico
    Ganeshanandan, Luckshman
    Peake, Jane
    Droney, Luke
    Williams, Andrew
    Celmeli, Fatih
    Hatipoglu, Nevin
    Ozcelik, Tayfun
    Picard, Capucine
    Abel, Laurent
    Tangye, Stuart G.
    Boisson-Dupuis, Stephanie
    Zhang, Qian
    Puel, Anne
    Beziat, Vivien
    Casanova, Jean-Laurent
    Boisson, Bertrand
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (08):
  • [9] STAT3 signaling and the hyper-IgE syndrome
    Levy, David E.
    Loomis, Cynthia A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16): : 1655 - 1658
  • [10] Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome
    Staudacher, Olga
    Krueger, Renate
    Koelsch, Uwe
    Thee, Stephanie
    Gratopp, Alexander
    Wahn, Volker
    Lau, Susanne
    von Bernuth, Horst
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01): : 349 - +